How much is the Primary Biliary Cholangitis Therapeutics Market market?

The primary biliary cholangitis therapeutics market market size is estimated to grow at $$ 346.85 mn in 2023. Read More

What is the growth rate of the Primary Biliary Cholangitis Therapeutics Market market?

The growth rate of the primary biliary cholangitis therapeutics market year-over-year is 8.75%. Read More

Which region held the largest market share in the Primary Biliary Cholangitis Therapeutics Market market?

North America is the region to held the largest market share with 50% growth. Read More

Who are the key players in the Primary Biliary Cholangitis Therapeutics Market market?

Abbott Laboratories, AbbVie Inc., Alkem Laboratories Ltd., Eli Lilly and Co., GENFIT SA, Glenmark Pharmaceuticals Ltd., ICE S.p.a., Intercept Pharmaceuticals Inc., Ipsen Pharma, .... Read More

Which Segment has the largest market share in the Primary Biliary Cholangitis Therapeutics Market market?

Type is the segment that has the largest market share in the market. Read More

Primary Biliary Cholangitis (PBC) Therapeutics Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, Canada, Germany, UK, China - Size and Forecast 2024-2028

Published: Nov 2023
Pages: 151
SKU: IRTNTR76783

Enjoy complimentary customisation on priority with our Enterprise License!

1 Executive Summary

1.1 Market overview
- Exhibit 01: Executive Summary – Chart on Market Overview
- Exhibit 02: Executive Summary – Data Table on Market Overview
- Exhibit 03: Executive Summary – Chart on Global Market Characteristics
- Exhibit 04: Executive Summary – Chart on Market by Geography
- Exhibit 05: Executive Summary – Chart on Market Segmentation by Type
- Exhibit 06: Executive Summary – Chart on Market Segmentation by Distribution Channel
- Exhibit 07: Executive Summary – Chart on Incremental Growth
- Exhibit 08: Executive Summary – Data Table on Incremental Growth
- Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem
- Exhibit 10: Parent market
- Exhibit 11: Market Characteristics

3 Market Sizing

3.1 Market definition
- Exhibit 12: Offerings of vendors included in the market definition

3.2 Market segment analysis
- Exhibit 13: Market segments

3.3 Market size 2023

3.4 Market outlook: Forecast for 2023-2028
- Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
- Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
- Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
- Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

4.1 Global primary biliary cholangitis therapeutics market 2018 - 2022
- Exhibit 18: Historic Market Size – Data Table on global primary biliary cholangitis therapeutics market 2018 - 2022 ($ million)

4.2 Type Segment Analysis 2018 - 2022
- Exhibit 19: Historic Market Size – Type Segment 2018 - 2022 ($ million)

4.3 Distribution Channel Segment Analysis 2018 - 2022
- Exhibit 20: Historic Market Size – Distribution Channel Segment 2018 - 2022 ($ million)

4.4 Geography Segment Analysis 2018 - 2022
- Exhibit 21: Historic Market Size – Geography Segment 2018 - 2022 ($ million)

4.5 Country Segment Analysis 2018 - 2022
- Exhibit 22: Historic Market Size – Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis

5.1 Five forces summary
- Exhibit 23: Five forces analysis - Comparison between 2023 and 2028

5.2 Bargaining power of buyers
- Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2023 and 2028

5.3 Bargaining power of suppliers
- Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2023 and 2028

5.4 Threat of new entrants
- Exhibit 26: Threat of new entrants – Impact of key factors in 2023 and 2028

5.5 Threat of substitutes
- Exhibit 27: Threat of substitutes – Impact of key factors in 2023 and 2028

5.6 Threat of rivalry
- Exhibit 28: Threat of rivalry – Impact of key factors in 2023 and 2028

5.7 Market condition
- Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Type

6.1 Market segments
- Exhibit 30: Chart on Type - Market share 2023-2028 (%)
- Exhibit 31: Data Table on Type - Market share 2023-2028 (%)

6.2 Comparison by Type
- Exhibit 32: Chart on Comparison by Type
- Exhibit 33: Data Table on Comparison by Type

6.3 Primary drug - Market size and forecast 2023-2028
- Exhibit 34: Chart on Primary drug - Market size and forecast 2023-2028 ($ million)
- Exhibit 35: Data Table on Primary drug - Market size and forecast 2023-2028 ($ million)
- Exhibit 36: Chart on Primary drug - Year-over-year growth 2023-2028 (%)
- Exhibit 37: Data Table on Primary drug - Year-over-year growth 2023-2028 (%)

6.4 Secondary drug - Market size and forecast 2023-2028
- Exhibit 38: Chart on Secondary drug - Market size and forecast 2023-2028 ($ million)
- Exhibit 39: Data Table on Secondary drug - Market size and forecast 2023-2028 ($ million)
- Exhibit 40: Chart on Secondary drug - Year-over-year growth 2023-2028 (%)
- Exhibit 41: Data Table on Secondary drug - Year-over-year growth 2023-2028 (%)

6.5 Market opportunity by Type
- Exhibit 42: Market opportunity by Type ($ million)
- Exhibit 43: Data Table on Market opportunity by Type ($ million)

7 Market Segmentation by Distribution Channel

7.1 Market segments
- Exhibit 44: Chart on Distribution Channel - Market share 2023-2028 (%)
- Exhibit 45: Data Table on Distribution Channel - Market share 2023-2028 (%)

7.2 Comparison by Distribution Channel
- Exhibit 46: Chart on Comparison by Distribution Channel
- Exhibit 47: Data Table on Comparison by Distribution Channel

7.3 Drug stores and retail pharmacies - Market size and forecast 2023-2028
- Exhibit 48: Chart on Drug stores and retail pharmacies - Market size and forecast 2023-2028 ($ million)
- Exhibit 49: Data Table on Drug stores and retail pharmacies - Market size and forecast 2023-2028 ($ million)
- Exhibit 50: Chart on Drug stores and retail pharmacies - Year-over-year growth 2023-2028 (%)
- Exhibit 51: Data Table on Drug stores and retail pharmacies - Year-over-year growth 2023-2028 (%)

7.4 Hospital pharmacies - Market size and forecast 2023-2028
- Exhibit 52: Chart on Hospital pharmacies - Market size and forecast 2023-2028 ($ million)
- Exhibit 53: Data Table on Hospital pharmacies - Market size and forecast 2023-2028 ($ million)
- Exhibit 54: Chart on Hospital pharmacies - Year-over-year growth 2023-2028 (%)
- Exhibit 55: Data Table on Hospital pharmacies - Year-over-year growth 2023-2028 (%)

7.5 Online pharmacies - Market size and forecast 2023-2028
- Exhibit 56: Chart on Online pharmacies - Market size and forecast 2023-2028 ($ million)
- Exhibit 57: Data Table on Online pharmacies - Market size and forecast 2023-2028 ($ million)
- Exhibit 58: Chart on Online pharmacies - Year-over-year growth 2023-2028 (%)
- Exhibit 59: Data Table on Online pharmacies - Year-over-year growth 2023-2028 (%)

7.6 Market opportunity by Distribution Channel
- Exhibit 60: Market opportunity by Distribution Channel ($ million)
- Exhibit 61: Data Table on Market opportunity by Distribution Channel ($ million)

8 Customer Landscape

8.1 Customer landscape overview
- Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

9.1 Geographic segmentation
- Exhibit 63: Chart on Market share by geography 2023-2028 (%)
- Exhibit 64: Data Table on Market share by geography 2023-2028 (%)

9.2 Geographic comparison
- Exhibit 65: Chart on Geographic comparison
- Exhibit 66: Data Table on Geographic comparison

9.3 North America - Market size and forecast 2023-2028
- Exhibit 67: Chart on North America - Market size and forecast 2023-2028 ($ million)
- Exhibit 68: Data Table on North America - Market size and forecast 2023-2028 ($ million)
- Exhibit 69: Chart on North America - Year-over-year growth 2023-2028 (%)
- Exhibit 70: Data Table on North America - Year-over-year growth 2023-2028 (%)

9.4 Europe - Market size and forecast 2023-2028
- Exhibit 71: Chart on Europe - Market size and forecast 2023-2028 ($ million)
- Exhibit 72: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
- Exhibit 73: Chart on Europe - Year-over-year growth 2023-2028 (%)
- Exhibit 74: Data Table on Europe - Year-over-year growth 2023-2028 (%)

9.5 Asia - Market size and forecast 2023-2028
- Exhibit 75: Chart on Asia - Market size and forecast 2023-2028 ($ million)
- Exhibit 76: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
- Exhibit 77: Chart on Asia - Year-over-year growth 2023-2028 (%)
- Exhibit 78: Data Table on Asia - Year-over-year growth 2023-2028 (%)

9.6 Rest of World (ROW) - Market size and forecast 2023-2028
- Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)

9.7 US - Market size and forecast 2023-2028
- Exhibit 83: Chart on US - Market size and forecast 2023-2028 ($ million)
- Exhibit 84: Data Table on US - Market size and forecast 2023-2028 ($ million)
- Exhibit 85: Chart on US - Year-over-year growth 2023-2028 (%)
- Exhibit 86: Data Table on US - Year-over-year growth 2023-2028 (%)

9.8 Canada - Market size and forecast 2023-2028
- Exhibit 87: Chart on Canada - Market size and forecast 2023-2028 ($ million)
- Exhibit 88: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
- Exhibit 89: Chart on Canada - Year-over-year growth 2023-2028 (%)
- Exhibit 90: Data Table on Canada - Year-over-year growth 2023-2028 (%)

9.9 Germany - Market size and forecast 2023-2028
- Exhibit 91: Chart on Germany - Market size and forecast 2023-2028 ($ million)
- Exhibit 92: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
- Exhibit 93: Chart on Germany - Year-over-year growth 2023-2028 (%)
- Exhibit 94: Data Table on Germany - Year-over-year growth 2023-2028 (%)

9.10 China - Market size and forecast 2023-2028
- Exhibit 95: Chart on China - Market size and forecast 2023-2028 ($ million)
- Exhibit 96: Data Table on China - Market size and forecast 2023-2028 ($ million)
- Exhibit 97: Chart on China - Year-over-year growth 2023-2028 (%)
- Exhibit 98: Data Table on China - Year-over-year growth 2023-2028 (%)

9.11 UK - Market size and forecast 2023-2028
- Exhibit 99: Chart on UK - Market size and forecast 2023-2028 ($ million)
- Exhibit 100: Data Table on UK - Market size and forecast 2023-2028 ($ million)
- Exhibit 101: Chart on UK - Year-over-year growth 2023-2028 (%)
- Exhibit 102: Data Table on UK - Year-over-year growth 2023-2028 (%)

9.12 Market opportunity by geography
- Exhibit 103: Market opportunity by geography ($ million)
- Exhibit 104: Data Tables on Market opportunity by geography ($ million)

10 Drivers, Challenges, and Trends

10.1 Market drivers

10.2 Market challenges

10.3 Impact of drivers and challenges
- Exhibit 105: Impact of drivers and challenges in 2023 and 2028

10.4 Market trends

11 Vendor Landscape

11.1 Overview

11.2 Vendor landscape
- Exhibit 106: Overview on Criticality of inputs and Factors of differentiation

11.3 Landscape disruption
- Exhibit 107: Overview on factors of disruption

11.4 Industry risks
- Exhibit 108: Impact of key risks on business

12 Vendor Analysis

12.1 Vendors covered
- Exhibit 109: Vendors covered

12.2 Market positioning of vendors
- Exhibit 110: Matrix on vendor position and classification

12.3 Abbott Laboratories
- Exhibit 111: Abbott Laboratories - Overview
- Exhibit 112: Abbott Laboratories - Business segments
- Exhibit 113: Abbott Laboratories - Key news
- Exhibit 114: Abbott Laboratories - Key offerings
- Exhibit 115: Abbott Laboratories - Segment focus

12.4 AbbVie Inc.
- Exhibit 116: AbbVie Inc. - Overview
- Exhibit 117: AbbVie Inc. - Product / Service
- Exhibit 118: AbbVie Inc. - Key news
- Exhibit 119: AbbVie Inc. - Key offerings

12.5 Alkem Laboratories Ltd.
- Exhibit 120: Alkem Laboratories Ltd. - Overview
- Exhibit 121: Alkem Laboratories Ltd. - Business segments
- Exhibit 122: Alkem Laboratories Ltd. - Key news
- Exhibit 123: Alkem Laboratories Ltd. - Key offerings
- Exhibit 124: Alkem Laboratories Ltd. - Segment focus

12.6 Eli Lilly and Co.
- Exhibit 125: Eli Lilly and Co. - Overview
- Exhibit 126: Eli Lilly and Co. - Product / Service
- Exhibit 127: Eli Lilly and Co. - Key news
- Exhibit 128: Eli Lilly and Co. - Key offerings

12.7 GENFIT SA
- Exhibit 129: GENFIT SA - Overview
- Exhibit 130: GENFIT SA - Product / Service
- Exhibit 131: GENFIT SA - Key offerings

12.8 Glenmark Pharmaceuticals Ltd.
- Exhibit 132: Glenmark Pharmaceuticals Ltd. - Overview
- Exhibit 133: Glenmark Pharmaceuticals Ltd. - Product / Service
- Exhibit 134: Glenmark Pharmaceuticals Ltd. - Key offerings

12.9 ICE S.p.a.
- Exhibit 135: ICE S.p.a. - Overview
- Exhibit 136: ICE S.p.a. - Product / Service
- Exhibit 137: ICE S.p.a. - Key offerings

12.10 Intercept Pharmaceuticals Inc.
- Exhibit 138: Intercept Pharmaceuticals Inc. - Overview
- Exhibit 139: Intercept Pharmaceuticals Inc. - Product / Service
- Exhibit 140: Intercept Pharmaceuticals Inc. - Key offerings

12.11 Ipsen Pharma
- Exhibit 141: Ipsen Pharma - Overview
- Exhibit 142: Ipsen Pharma - Business segments
- Exhibit 143: Ipsen Pharma - Key offerings
- Exhibit 144: Ipsen Pharma - Segment focus

12.12 Leeford Healthcare Ltd.
- Exhibit 145: Leeford Healthcare Ltd. - Overview
- Exhibit 146: Leeford Healthcare Ltd. - Key offerings

12.13 NGM Biopharmaceuticals Inc.
- Exhibit 147: NGM Biopharmaceuticals Inc. - Overview
- Exhibit 148: NGM Biopharmaceuticals Inc. - Key offerings

12.14 Novartis AG
- Exhibit 149: Novartis AG - Overview
- Exhibit 150: Novartis AG - Business segments
- Exhibit 151: Novartis AG - Key offerings
- Exhibit 152: Novartis AG - Segment focus

12.15 Teva Pharmaceutical Industries Ltd.
- Exhibit 153: Teva Pharmaceutical Industries Ltd. - Overview
- Exhibit 154: Teva Pharmaceutical Industries Ltd. - Business segments
- Exhibit 155: Teva Pharmaceutical Industries Ltd. - Key news
- Exhibit 156: Teva Pharmaceutical Industries Ltd. - Key offerings
- Exhibit 157: Teva Pharmaceutical Industries Ltd. - Segment focus

12.16 Viatris Inc.
- Exhibit 158: Viatris Inc. - Overview
- Exhibit 159: Viatris Inc. - Business segments
- Exhibit 160: Viatris Inc. - Key news
- Exhibit 161: Viatris Inc. - Key offerings
- Exhibit 162: Viatris Inc. - Segment focus

12.17 Zydus Lifesciences Ltd.
- Exhibit 163: Zydus Lifesciences Ltd. - Overview
- Exhibit 164: Zydus Lifesciences Ltd. - Business segments
- Exhibit 165: Zydus Lifesciences Ltd. - Key offerings
- Exhibit 166: Zydus Lifesciences Ltd. - Segment focus

13 Appendix

13.1 Scope of the report

13.2 Inclusions and exclusions checklist
- Exhibit 167: Inclusions checklist
- Exhibit 168: Exclusions checklist

13.3 Currency conversion rates for US$
- Exhibit 169: Currency conversion rates for US$

13.4 Research methodology
- Exhibit 170: Research methodology
- Exhibit 171: Validation techniques employed for market sizing
- Exhibit 172: Information sources

13.5 List of abbreviations
- Exhibit 173: List of abbreviations

Research Framework

Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

INFORMATION SOURCES